ABL Diagnostics (Euronext Paris, FR001400AHX6, ABLD), specializing in the development of diagnostic tests for infectious diseases, based on genotyping by sequencing, is pleased to announce that it has obtained ISO 13485:2016 certification for its design, development, manufacture, sale and associated services (installation, maintenance) of in vitro diagnostic kits used for the molecular diagnosis of infectious pathologies (HIV, tuberculosis, viral hepatitis, etc.)